Massachusetts Campaign Turns In Final Signatures To Put Psychedelics Legalization On The November Ballot
Alabama Judge Further Delays State’s Stalled Medical Marijuana Licensing Process
Kentucky Governor Beshear Promotes Marijuana Work With VP Harris Amid Speculation On Presidential Ticket Shakeup
Maryland Officials Update Cannabis Tax Report Over Clerical Error
New Bipartisan Congressional Bill Would Expunge Federal Marijuana Records
Older Patients Using Medical Cannabis ‘Experience Considerable Improvement In Health And Well-Being,’ Study Finds
Youth See Reddit As ‘Viable Outlet’ For Marijuana Info, But Posts Often Have ‘Lack Of Verifiable’ Facts, Study Finds
People’s Use Of Alcohol Or Opioids Causes Greater Secondhand Harms Than Marijuana Consumption Does, Study Finds
Youth Marijuana Use In Colorado Continues To Decline Since Legalization Took Effect, Contradicting Prohibitionist Fears
Communities Closer To Marijuana Dispensaries Have Lower Opioid Prescription Rates, New Study Finds
NCAA Votes To Remove Marijuana From Banned Substances List For College Athletes
California State Fair Will Allow Marijuana Sales And On-Site Consumption For First Time
Marijuana Rolling Paper Company Will Pay $4.20 To Volunteers To ‘Smoke Joints For Science’
NFL Sued By Player Who Was Fined Over $500,000 For Positive THC Tests Caused By Prescribed Cannabis Medication
Brands And Advocacy Groups—From ACLU To KFC—Launch 4/20 Promotions To Mark The Marijuana Holiday
Maryland Sees More Than $1.1 Billion In Marijuana Sales During Legal Market’s First Year
Oregon’s First-In-Nation Psilocybin Industry Is Struggling To Find Paying Customers A Year After Launching
States Have Generated Over $20 Billion In Marijuana Tax Revenue Since First Markets Opened, New Report Finds
Arkansas Medical Marijuana Dispensary Gets License Revoked Over Alleged Violations
New Jersey Set A New Marijuana Sales Record Last Quarter, With Regulators Touting ‘Historical Highs’ On 4/20 Weekend
Kentucky Governor Beshear Promotes Marijuana Work With VP Harris Amid Speculation On Presidential Ticket Shakeup
Biden Touts Work To Address ‘Failed Approach To Marijuana’ In Civil Rights Act Proclamation
Marijuana Rescheduling Won’t Affect Drug Testing For Truckers, Transportation Secretary Buttigieg Says
DeSantis Says Florida Legalization Ballot Measure Would Protect Marijuana Rights More Than 1st And 2nd Amendments Protect Free Speech And Gun Rights
North Carolina Senate Passes Bill To Legalize Medical Marijuana, But House Speaker Says It Needs Majority GOP Support For Floor Vote There
Cannabis rescheduling will let DC legalize sales (Newsletter: July 3, 2024)
Federal cannabis lawsuit dismissed (Newsletter: July 2, 2024)
IRS warns cannabis businesses about 280E tax refunds (Newsletter: July 1, 2024)
Biden ads slam Trump’s cannabis stance (Newsletter: June 28, 2024)
Biden vs. Trump on cannabis (Newsletter: June 27, 2024)
Published
on
By
The Democratic governor of Arizona has vetoed a bill to legalize psilocybin service centers where people could receive the psychedelic in a medically supervised setting.
Less than a week after lawmakers gave final approval to the legislation, Gov. Katie Hobbs (D) rejected it on Tuesday, arguing that while the psychedelic may hold therapeutic potential, “we do not yet have the evidence needed to support widespread clinical expansion.”
“Arizonans with depression and PTSD deserve access to treatments that may be seen as outside the mainstream, but they should not be the subject of experiments for unproven therapies with a lack of appropriate guardrails,” the governor said in a veto message.
She also said that the bill’s estimated cost is $400,000 per year, which wasn’t accounted for in the budget.
Under the now-vetoed legislation, the Department of Human Services (DHS) would have been authorized to license psilocybin-assisted therapy centers in the state, where trained facilitators could have administered the psychedelic.
The measure would have significantly expanded on Arizona’s existing research-focused psychedelics law that provides $5 million in annual funding to support studies into psilocybin therapy.
Hobbs cited that research funding in her statement, saying the goal is to “ensure that those who seek psilocybin treatment are doing so confidently and safely under proper supervision of qualified professionals with documented and verified research to support the treatment.”
She said that money “will be allowed to continue with this year’s budget,” with a separate funding bill she signed into law on Tuesday protecting those dollars, which are exempt from lapsing appropriations provisions.
The vetoed proposal, meanwhile, would have established an Arizona Psilocybin Advisory Board, comprised of members appointed by the governor and legislative leaders. Representatives of the attorney general’s office and DHS, as well as military veterans, first responders, scientists with experience with psilocybin and physicians would have been among the members.
The board would have been responsible for establishing training criteria for psilocybin service center staff, making recommendations on the implementation of the law, and studying the science and policy developments related to psychedelics.
Sen. T. J. Shope (R), the bill’s sponsor, told The Center Square that the veto is a “disappointing result after months of hard work and the overwhelming bipartisan support this received in both houses of the Legislature this year.”
The senator added that if lawmakers were still in session, he’d be pushing for a vote to override the veto, but he’ll have to “settle for trying again next year.”
.@TJShope, the bill’s sponsor, texted me this in response to the veto. pic.twitter.com/1ArqtCc8vy
— Cameron Arcand (@cameron_arcand) June 19, 2024
“I won’t stop fighting for our veterans and first responders to get the mental health care they deserve in these clinical settings,” he said. “Sadly, Arizonans will now have to continue leaving their own state and country to receive this type of treatment. It’s truly a sad day for those who have put everything on the line for us.”
The governor’s veto is reminiscent of a similar setback for advocates in California last year, with Gov. Gavin Newsom (D) vetoing a bill to legalize certain psychedelics.
—
Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
In any case, there are multiple states where lawmakers have been working to promote research into psychedelics amid growing public interest in expanding therapeutic access and ending criminalization.
California lawmakers have separately revised a psilocybin pilot program bill to narrow eligibility criteria for participants and facilitators who could administer the psychedelic under the proposal.
A New Jersey Assembly committee also recently adopted an amendment to a psilocybin bill that aligns its provisions with a Senate companion version, removing language to more broadly legalize the psychedelic and instead focusing on therapeutic use.
Last week the Massachusetts Senate approved a bill focused focused on military veterans that includes provisions to create a psychedelics working group to study and make recommendations about the potential therapeutic benefits of substances like psilocybin and MDMA.
Last month, Vermont Gov. Phil Scott (R) signed a bill into law to create a psychedelic-assisted therapy working group that will make recommendations on whether and how the state should regulate legal access to substances such as psilocybin and MDMA.
Maryland Gov. Wes Moore (D) signed legislation last month to create a psychedelics task force responsible for studying possible regulatory frameworks for therapeutic access to substances such as psilocybin, mescaline and DMT. It would be charged specifically with ensuring “broad, equitable and affordable access to psychedelic substances” in the state.
Last month in Alaska lawmakers sent the governor a bill to create a state task force to study how to license and regulate psychedelic-assisted therapy in the event of federal approval of substances such as MDMA and psilocybin.
Indiana’s governor recently signed a bill that includes provisions to fund clinical research trials into psilocybin.
Utah’s governor, meanwhile, allowed a bill to authorize a pilot program for hospitals to administer psilocybin and MDMA as an alternative treatment option to become law without his signature.
Maine lawmakers sent the governor legislation to establish a commission tasked with studying and making recommendations on regulating access to psychedelic services.
A Connecticut joint legislative panel approved a bill to decriminalize possession of psilocybin.
The governor of New Mexico has endorsed a newly enacted resolution requesting that state officials research the therapeutic potential of psilocybin and explore the creation of a regulatory framework to provide access to the psychedelic.
An Illinois committee also recently held a hearing to discuss a bill to legalize psilocybin and allow regulated access at service centers in the state where adults could use the psychedelic in a supervised setting—with plans to expand the program to include mescaline, ibogaine and DMT.
Lawmakers in Hawaii also considered a bill that would provide some legal protections to patients engaging in psilocybin-assisted therapy with a medical professional’s approval.
New York lawmakers said that a bill to legalize psilocybin-assisted therapy in that state has a “real chance” of passing this year.
A Nevada joint legislative committee held a hearing with expert and public testimony on the therapeutic potential of substances like psilocybin in January. Law enforcement representatives also shared their concerns around legalization—but there was notable acknowledgement that some reforms should be enacted, including possible rescheduling.
New Hampshire Lawmakers And Advocates Blame Each Other Over Marijuana Legalization Bill’s Defeat
Photo courtesy of Wikimedia/Mushroom Observer.
Delaware House Passes Bill To Launch Recreational Marijuana Sales Early Through Existing Medical Cannabis Dispensaries
New Hampshire Lawmakers And Advocates Blame Each Other Over Marijuana Legalization Bill’s Defeat
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Massachusetts Campaign Turns In Final Signatures To Put Psychedelics Legalization On The November Ballot
Maryland Sees More Than $1.1 Billion In Marijuana Sales During Legal Market’s First Year
Alabama Judge Further Delays State’s Stalled Medical Marijuana Licensing Process
Kentucky Governor Beshear Promotes Marijuana Work With VP Harris Amid Speculation On Presidential Ticket Shakeup
Maryland Officials Update Cannabis Tax Report Over Clerical Error
New Bipartisan Congressional Bill Would Expunge Federal Marijuana Records
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell